Journal
|
Published
|
Author(s)
|
Title
|
Therapeutic Delivery, 12(3), pp. 235-244
|
2021
|
Shahcheraghi, S.H., Ayatollahi, J., Aljabali, A.A.A., (...), Bakshi,
H.A., Tambuwala, M.M.
|
An overview of
vaccine development for COVID-19
|
Current Molecular Pharmacology, 14(1), pp. 79-87
|
2021
|
Shahcheraghi, S.H., Lotfi, M., Soukhtanloo, M., (...), Sadeghnia,
H.R., Ghorbani, A.
|
Effects of galbanic
acid on proliferation, migration, and apoptosis of glioblastoma cells through
the pi3k/akt/mtor signaling pathway
|
Life Sciences, 278,119632
|
2021
|
Shahcheraghi, S.H., Aljabali, A.A.A., Al Zoubi, M.S., (...),
Bakshi, H.A., Tambuwala, M.M.
|
Overview of key molecular and pharmacological targets for diabetes
and associated diseases
|
Reproductive Sciences, 28(7), pp. 2050-2059
|
2021
|
Aflatoonian, A., Lotfi, M., Saeed, L., Tabibnejad, N.
|
Effects of Intraovarian Injection of Autologous Platelet-Rich
Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary
Ovarian Insufficiency
|
Current Pharmaceutical Design, 26(15), pp. 1729-1741
|
2020
|
Shahcheraghi, S.H., Tchokonte-Nana, V., Lotfi, M., (...),
Ghorbani, A., Sadeghnia, H.R.
|
Wnt/beta-catenin and
pi3k/akt/mtor signaling pathways in glioblastoma: Two main targets for drug
design: A review
|